DeDora Capital’s Dentsply Sirona XRAY Stock Holding History

DeDora Capital’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-251	Closed	-$12K	–	398
2022 Q1	$12K	Buy	+251	New	+$13.3K	﹤0.01%	299

Other funds holding XRAY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DeDora Capital's XRAY Position: Q2 2022 in Review

DeDora Capital sold out of Dentsply Sirona (XRAY) in Q2 2022, closing a stake of 251 shares — an estimated $12K sold.

DeDora Capital first reported a position in XRAY in Q1 2022 and held it in 1 quarter. The position peaked at $12K in Q1 2022. 470 funds tracked by Wall St. Rank hold XRAY as of Q2 2022.

DeDora Capital reported no remaining Dentsply Sirona position as of Q2 2022 after selling out during the quarter.
DeDora Capital sold 251 Dentsply Sirona shares in Q2 2022, an estimated $12K.
DeDora Capital first reported a position in Dentsply Sirona in Q1 2022 and held it in 1 quarter.
DeDora Capital's Dentsply Sirona position peaked at $12K in Q1 2022.
470 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2022.

Based on DeDora Capital's 13F filing for Q2 2022, filed 27 Jul 2022.